Related references
Note: Only part of the references are listed.Genetics of Synucleinopathies
Robert L. Nussbaum
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease
Kelly M. Lohr et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2017)
Genome-wide association study of Parkinson's disease in East Asians
Jia Nee Foo et al.
HUMAN MOLECULAR GENETICS (2017)
Cardiac parasympathetic dysfunction in the early phase of Parkinson's disease
Masashi Suzuki et al.
JOURNAL OF NEUROLOGY (2017)
Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson's Disease
Junjun Zhao et al.
MOLECULAR NEUROBIOLOGY (2017)
Constipation in Parkinson's Disease: Subjective Symptoms, Objective Markers, and New Perspectives
Karoline Knudsen et al.
MOVEMENT DISORDERS (2017)
MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian
Mingshu Mo et al.
ONCOTARGET (2017)
Neurotransmitters: The Critical Modulators Regulating Gut-Brain Axis
Rahul Mittal et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis
David Irwin et al.
LANCET NEUROLOGY (2017)
Parkin loss-of-function pathology: Premature neuronal senescence induced by high levels of reactive oxygen species?
Lori M. Buhlman
MECHANISMS OF AGEING AND DEVELOPMENT (2017)
Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story
Yannick Vermeiren et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
GENOME-WIDE PATHWAY-BASED ASSOCIATION ANALYSIS IDENTIFIES RISK PATHWAYS ASSOCIATED WITH PARKINSON'S DISEASE
Mingming Zhang et al.
NEUROSCIENCE (2017)
Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis
Yi Xie et al.
NEUROSCIENCE LETTERS (2017)
Role of the VPS35 D620N mutation in Parkinson's disease
Megha Mohan et al.
PARKINSONISM & RELATED DISORDERS (2017)
Whole-exome sequencing of 228 patients with sporadic Parkinson's disease
Cynthia Sandor et al.
SCIENTIFIC REPORTS (2017)
Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation
Dharmin Rokad et al.
BRAIN RESEARCH BULLETIN (2017)
Neuroprotective Effect of Atremorine in an Experimental Model of Parkinson's Disease
Ivan Carrera et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Interaction between subclinical doses of the Parkinson's disease associated gene, α-synuclein, and the pesticide, rotenone, precipitates motor dysfunction and nigrostriatal neurodegeneration in rats
Carol Naughton et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis
Frederic Moisan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
LRRK2 deficiency impacts ceramide metabolism in brain
Ruggero Ferrazza et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease
Felipe Roberti Teixeira et al.
BIOCHEMICAL JOURNAL (2016)
Phenome-based gene discovery provides information about Parkinson's disease drug targets
Yang Chen et al.
BMC GENOMICS (2016)
Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review
Zahra Goodarzi et al.
BMC NEUROLOGY (2016)
Specificity and impact of adrenergic projections to the midbrain dopamine system
Carlos A. Mejias-Aponte
BRAIN RESEARCH (2016)
Norepinephrine versus dopamine and their interaction in modulating synaptic function in the prefrontal cortex
Bo Xing et al.
BRAIN RESEARCH (2016)
Association Analysis of Proteasome Subunits and Transporter Associated with Antigen Processing on Chinese Patients with Parkinson's Disease
Ming-Shu Mo et al.
CHINESE MEDICAL JOURNAL (2016)
Advances in understanding genomic markers and pharmacogenetics of Parkinson's disease
Felix Javier Jimenez-Jimenez et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Identification of genetic modifiers of age-at-onset for familial Parkinson's disease
Erin M. Hill-Burns et al.
HUMAN MOLECULAR GENETICS (2016)
Estimating the prevalence of Parkinson's disease (PD) and proportions of patients with associated dementia and depression among the older adults based on secondary claims data
O. Riedel et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2016)
Nuclear organization of the substantia nigra, ventral tegmental area and retrorubral field of the common marmoset (Callithrix jacchus): A cytoarchitectonic and TH-immunohistochemistry study
Jose R. L. P. Cavalcanti et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2016)
Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects
Toshiharu Nagatsu et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
The relationship between glucocerebrosidase mutations and Parkinson disease
Anna Migdalska-Richards et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system
Douglas L. Feinstein et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Current and experimental treatments of Parkinson disease: A guide for neuroscientists
Wolfgang Oertel et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Mitochondrial dysfunction in Parkinson's disease
Anindita Bose et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance
Dena G. Hernandez et al.
JOURNAL OF NEUROCHEMISTRY (2016)
SNCA rs356182 variant increases risk of sporadic Parkinson's disease in ethnic Chinese
Lan Cheng et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Association between MDR1 gene polymorphisms and Parkinson's disease in Asian and Caucasian populations: a meta-analysis
Shiek S. S. J. Ahmed et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment
Paolo Barone et al.
LANCET NEUROLOGY (2016)
LRRK2 interferes with aggresome formation for autophagic clearance
Yeojin Bang et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2016)
Genetics of Parkinson's disease
Christina M. Lill
MOLECULAR AND CELLULAR PROBES (2016)
A Novel RAB39B Gene Mutation in X-Linked Juvenile Parkinsonism With Basal Ganglia Calcification
Chang-he Shi et al.
MOVEMENT DISORDERS (2016)
Identification of TMEM230 mutations in familial Parkinson's disease
Han-Xiang Deng et al.
NATURE GENETICS (2016)
The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis
Lauren Hirsch et al.
NEUROEPIDEMIOLOGY (2016)
Monoamine transporter contributions to L-DOPA effects in hemi-parkinsonian rats
Melissa M. Conti et al.
NEUROPHARMACOLOGY (2016)
Association of DYRK1A polymorphisms with sporadic Parkinson's disease in Chinese Han population
Luan Cen et al.
NEUROSCIENCE LETTERS (2016)
Pharmacogenetic considerations in the treatment of Alzheimer's disease
Ramon Cacabelos et al.
PHARMACOGENOMICS (2016)
Influence of genetic, biological and pharmacological factors on levodopa dose in Parkinson's disease
Vivian Altmann et al.
PHARMACOGENOMICS (2016)
Oxidation and interaction of DJ-1 with 20S proteasome in the erythrocytes of early stage Parkinson's disease patients
Yoshiro Saito et al.
SCIENTIFIC REPORTS (2016)
Parkin Regulation and Neurodegenerative Disorders
Cheng-Wu Zhang et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
Professional ethics in complementary and alternative medicines in management of Parkinson's disease
Hee Jin Kim et al.
JOURNAL OF PARKINSONS DISEASE (2016)
Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD)
Zhi Dong Zhou et al.
MOLECULAR BRAIN (2016)
C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease
Alexandra Kleinknecht et al.
PLOS GENETICS (2016)
Time Trends in the Incidence of Parkinson Disease
Rodolfo Savica et al.
JAMA NEUROLOGY (2016)
The biomarkers of immune dysregulation and inflammation response in Parkinson disease
Li Chen et al.
TRANSLATIONAL NEURODEGENERATION (2016)
Telomere shortening leads to an acceleration of synucleinopathy and impaired microglia response in a genetic mouse model
Annika Scheffold et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review
Ke-xin Wen et al.
PLOS ONE (2016)
Striatal dopamine neurotransmission: Regulation of release and uptake
David Sulzer et al.
BASAL GANGLIA (2016)
Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease
Caroline Moreau et al.
BRAIN (2015)
Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies
Tanja Tran et al.
CNS DRUGS (2015)
Anticholinergic burden in Parkinson's disease inpatients
Unax Lertxundi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Lesion of medullary catecholaminergic neurons is associated with cardiovascular dysfunction in rotenone-induced Parkinson's disease rats
Zhaoqiang Zhang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2015)
Asian perspectives on the recognition and management of levodopa 'wearing-off' in Parkinson's disease
Roongroj Bhidayasiri et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response
Ramon Cacabelos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus
Kazumasa Wakamatsu et al.
JOURNAL OF NEUROCHEMISTRY (2015)
CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study
Manabu Funayama et al.
LANCET NEUROLOGY (2015)
Biomarkers of Parkinson's disease: Present and future
Diane B. Miller et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
New Treatments for Levodopa-Induced Motor Complications
Olivier Rascol et al.
MOVEMENT DISORDERS (2015)
Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease
G. Levandis et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2015)
Is there a role for ADORA2A polymorphisms in levodopa-induced dyskinesia in Parkinson's disease patients?
Mariana Rieck et al.
PHARMACOGENOMICS (2015)
The epigenetics of aging and neurodegeneration
Roy Lardenoije et al.
PROGRESS IN NEUROBIOLOGY (2015)
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era
Aline Verstraeten et al.
TRENDS IN GENETICS (2015)
Risk of Disabling Response Fluctuations and Dyskinesias for Dopamine Agonists Versus Levodopa in Parkinson's Disease
Charlotte A. Haaxma et al.
JOURNAL OF PARKINSONS DISEASE (2015)
Asian perspectives on the recognition and management of levodopa 'wearing-off' in Parkinson's disease
Roongroj Bhidayasiri et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Monoamine transporters: insights from molecular dynamics simulations
Julie Grouleff et al.
FRONTIERS IN PHARMACOLOGY (2015)
Prolactin and sex hormones levels in males with Parkinson's disease
M. Nitkowska et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
Parkinson's Disease Correlates With Promoter Methylation in the α-Synuclein Gene
Lasse Pihlstrom et al.
MOVEMENT DISORDERS (2015)
Levodopa: Effect on Cell Death and the Natural History of Parkinson's Disease
C. Warren Olanow
MOVEMENT DISORDERS (2015)
Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
Chandana Buddhala et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Opportunities in pharmacogenomics for the treatment of Alzheimer's disease
Ramon Cacabelos et al.
FUTURE NEUROLOGY (2015)
Pharmacogenetic considerations in the treatment of Parkinson's disease
Mateusz Kurzawski et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2015)
Effects of hypothalamic dopamine (DA) on salsolinol (SAL)-induced prolactin (PRL) secretion in male goats
Jin Jin et al.
ANIMAL SCIENCE JOURNAL (2014)
Noradrenergic Regulation of Glial Activation: Molecular Mechanisms and Therapeutic Implications
David Braun et al.
CURRENT NEUROPHARMACOLOGY (2014)
Epigenetic drug discovery for Alzheimer's disease
Ramon Cacabelos et al.
EXPERT OPINION ON DRUG DISCOVERY (2014)
Norepinephrine Deficiency in Parkinson's Disease: The Case for Noradrenergic Enhancement
Alberto J. Espay et al.
MOVEMENT DISORDERS (2014)
The Prevalence of Parkinson's Disease: A Systematic Review and Meta-analysis
Tamara Pringsheim et al.
MOVEMENT DISORDERS (2014)
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Mike A. Nalls et al.
NATURE GENETICS (2014)
Epigenome-Wide Association Study for Parkinson's Disease
Kerry Moore et al.
NEUROMOLECULAR MEDICINE (2014)
Parkinson's disease pharmacogenomics: new findings and perspectives
Artur F. Schumacher-Schuh et al.
PHARMACOGENOMICS (2014)
Association of common genetic variants of HOMER1 gene with levodopa adverse effects in Parkinson's disease patients
A. F. Schumacher-Schuh et al.
PHARMACOGENOMICS JOURNAL (2014)
Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo
Kelly M. Lohr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
New perspectives on catecholaminergic regulation of executive circuits: evidence for independent modulation of prefrontal functions by midbrain dopaminergic and noradrenergic neurons
Daniel J. Chandler et al.
FRONTIERS IN NEURAL CIRCUITS (2014)
Presynaptic mechanisms of L-DOPA-induced dyskinesia: the findings, the debate, and the therapeutic implications
M. Angela Cenci
FRONTIERS IN NEUROLOGY (2014)
L-DOPA attenuates prolactin secretion in response to isolation stress in Holstein steers
Etsuko Kasuya et al.
ANIMAL SCIENCE JOURNAL (2013)
Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre
Jon B. Toledo et al.
BRAIN (2013)
Distinctive patterns of DNA methylation associated with Parkinson disease Identification of concordant epigenetic changes in brain and peripheral blood leukocytes
Eliezer Masliah et al.
EPIGENETICS (2013)
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
C. Warren Olanow et al.
MOVEMENT DISORDERS (2013)
Epigenetic Landscape of Parkinson's Disease: Emerging Role in Disease Mechanisms and Therapeutic Modalities
Navneet Ammal Kaidery et al.
NEUROTHERAPEUTICS (2013)
Meta-analysis of Parkinson's Disease: Identification of a novel locus, RIT2
Nathan Pankratz et al.
ANNALS OF NEUROLOGY (2012)
Cardiovascular dysautonomia in Parkinson disease: From pathophysiology to pathogenesis
Samay Jain et al.
NEUROBIOLOGY OF DISEASE (2012)
Genome Wide Assessment of Young Onset Parkinson's Disease from Finland
Dena G. Hernandez et al.
PLOS ONE (2012)
DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson's disease patients
Mariana Rieck et al.
PHARMACOGENOMICS (2012)
Genetics and Epigenetics of Parkinson's Disease
Fabio Coppede
SCIENTIFIC WORLD JOURNAL (2012)
Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database
Christina M. Lill et al.
PLOS GENETICS (2012)
Genome-Wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population
Xinmin Liu et al.
BMC MEDICAL GENETICS (2011)
Genome-wide association study confirms extant PD risk loci among the Dutch
Javier Simon-Sanchez et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Diurnal Secretion Profiles of Growth Hormone, Thyrotrophin and Prolactin in Parkinson's Disease
N. A. Aziz et al.
JOURNAL OF NEUROENDOCRINOLOGY (2011)
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies
Michael A. Nalls et al.
LANCET (2011)
Parkinson's Disease as a Neuroendocrine Disorder of Circadian Function: Dopamine-Melatonin Imbalance and the Visual System in the Genesis and Progression of the Degenerative Process
Gregory L. Willis
REVIEWS IN THE NEUROSCIENCES (2011)
Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease
Chuong B. Do et al.
PLOS GENETICS (2011)
Genome-Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease
Todd L. Edwards et al.
ANNALS OF HUMAN GENETICS (2010)
Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update
Karen Nuytemans et al.
HUMAN MUTATION (2010)
Levodopa-related wearing-off in Parkinson's disease: identification and management
Rajesh Pahwa et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Genomewide association study for susceptibility genes contributing to familial Parkinson disease
Nathan Pankratz et al.
HUMAN GENETICS (2009)
Systematic Review of the Prevalence and Incidence of Parkinson's Disease in Asia
Weerasak Muangpaisan et al.
JOURNAL OF EPIDEMIOLOGY (2009)
A case of 6-Pyruvoyl-tetrahydropterin. synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels
Atsushi Ogawa et al.
BRAIN & DEVELOPMENT (2008)
Pituitary function and the somatotrophic system in patients with idiopathic Parkinson's disease under chronic dopaminergic therapy
S. Schaefer et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Regulation of growth hormone and prolactin gene expression and secretion by chimeric somatostatin-dopamine molecules
Anna Gruszka et al.
ENDOCRINOLOGY (2007)
Norepinephrine: The redheaded stepchild of 'Parkinson's disease'
K. S. Rommelfanger et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Endurance exercise modulates levodopa induced growth hormone release in patients with Parkinson's disease
Thomas Mueller et al.
NEUROSCIENCE LETTERS (2007)
The peripheral noradrenergic terminal as possible site of action of salsolinol as prolactoliberin
D. Szekacs et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Prevalence and incidence of Parkinson's disease in Europe
S von Campenhausen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
Serum prolactin levels in Parkinson's disease and multiple system atrophy
AS Winkler et al.
CLINICAL AUTONOMIC RESEARCH (2002)
Share Paper
